Compounds > aristolochic acid i

aristolochic acid i and dicumarol

aristolochic acid i has been researched along with dicumarol in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Chen, M; Gong, L; Li, Y; Luan, Y; Pan, G; Qi, X; Ren, J; Wu, Y; Xiao, Y; Xing, G; Xue, X; Yao, J1
Arlt, VM; Bárta, F; Frei, E; Levová, K; Schmeiser, HH; Stiborová, M; Šulc, M1
Arlt, VM; Barta, F; Dracinska, H; Frei, E; Hodek, P; Levova, K; Schmeiser, HH; Stiborova, M; Sulc, M1
Chang, SY; Chapron, A; Dickman, KG; Eaton, DL; Gao, C; Grollman, AP; Himmelfarb, J; Kelly, EJ; Mao, Q; Neumann, T; Rosenquist, TA; Shen, D; Sidorenko, VS; Wang, J; Weber, EJ; Yeung, CK1

Other Studies

5 other study(ies) available for aristolochic acid i and dicumarol

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity.
    Toxicological sciences : an official journal of the Society of Toxicology, 2011, Volume: 122, Issue:2

    Topics: Animals; Aristolochic Acids; Dicumarol; Enzyme Inhibitors; Epithelial Cells; Gene Expression; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; NAD(P)H Dehydrogenase (Quinone); Phenindione; Survival Rate

2011
The influence of dicoumarol on the bioactivation of the carcinogen aristolochic acid I in rats.
    Mutagenesis, 2014, Volume: 29, Issue:3

    Topics: Activation, Metabolic; Animals; Aristolochic Acids; Carcinogens; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochromes; Cytosol; Dicumarol; DNA Adducts; Humans; Kidney; Liver; Male; Mice; Microsomes, Liver; Mutagenicity Tests; Mutagens; NAD(P)H Dehydrogenase (Quinone); Rats; Rats, Wistar

2014
Dicoumarol inhibits rat NAD(P)H:quinone oxidoreductase in vitro and induces its expression in vivo.
    Neuro endocrinology letters, 2014, Volume: 35 Suppl 2

    Topics: Animals; Aristolochic Acids; Dicumarol; Enzyme Inhibitors; Humans; Quinone Reductases; Rats

2014
Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.
    JCI insight, 2017, 11-16, Volume: 2, Issue:22

    Topics: Animals; Aristolochic Acids; Biomarkers; Biotransformation; Carcinogens; Dicumarol; Epithelial Cells; Hepatocytes; Humans; Kidney; Liver; Male; Multidrug Resistance-Associated Proteins; NAD(P)H Dehydrogenase (Quinone); Nephrons; Pathology, Molecular; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Xenobiotics

2017